Hypoglycemia awareness and burden among hospitalized patients at high risk for hypoglycemia.

Background: Hypoglycemia, a common complication of insulin therapy in patients with diabetes, is associated with increased hospital morbidity and mortality. Hypoglycemia may be underrecognized in hospitalized patients due to impaired counter regulation or reduced recognition. Beta blocker (BB) use may also affect hypoglycemia recognition.
Aim: To characterize hypoglycemia unawareness and patient perceived hypoglycemia burden in hospitalized patients.
Materials and Methods: Over a 2-month period, we prospectively identified non-critically ill cognitively intact hospitalized insulin-requiring patients who were undergoing bedside glucose monitoring. Participants were included if they reported any episode of hypoglycemia in the 30 days prior to admission and either had no BB use or were on stable BB for 90 days. Hypoglycemia unawareness was assessed using the Clarke score and burden of hypoglycemia was assessed with the (TRIM-HYPO) score.
Results: Of the 46 participants, 20 were not taking a BB and 26 were taking a BB. Predictors of hypoglycemia during admission included glucose coefficient of variation and hospital length of stay. Nine participants (20%) had hypoglycemia unawareness (Clarke score ≥4). Participants with a history of coronary artery disease were less likely to have impaired awareness. Burden of hypoglycemia was associated with more hypoglycemia and longer hospital length of stay. There were no differences in measures of hypoglycemia unawareness or burden according to BB use.
Conclusions: BB use was not related to hypoglycemia unawareness, or burden in hospitalized high risk patients. Hypoglycemia burden may identify patients at higher risk of hypoglycemia during admission.
Competing Interests: Declaration of competing interest Kathleen Dungan, MD discloses research support from Sanofi Aventis, Novo Nordisk, Eli Lilly, consulting activities with Eli Lilly. Clarine Long has no competing interest to disclose.
(Copyright © 2020 Elsevier Inc. All rights reserved.)